Introduction {#Sec1}
============

Evidence-based guidelines now endorse using genetics-informed assessments to stratify populations on cancer risk^[@CR1]^. The rationale is that such risk information enables a veritable "win-win" that enables prevention and early detection strategies to be tailored to improve health outcomes while reducing patient burden and health care costs. Concurrently, the US Preventative Services Task Force (USPSTF) has updated screening mammography recommendations holding that asymptomatic individuals who are at low risk for familial breast cancer syndromes (such as hereditary breast and ovarian cancer syndrome \[HBOC\]) begin mammogram screening at age 50 and that women have biannual mammograms^[@CR2],[@CR3]^. Similarly, the American Cancer Society (ACS) announced in 2015 that, it had modified its recommendations to align more closely with the USPSTF^[@CR4]^. ACS's stated rationale was that the modification better balanced the potential benefit of early detection against the now-clearer evidence about the risks of false alarms and overtreatment^[@CR5]^.

Brief family history screening tools have been scientifically validated for use to stratify risk^[@CR1]^ and provide guidance regarding who should get a mammogram and when. Implementation of these risk assessment tools at the population level as supported by the CDC Tier 1 evidence^[@CR6]^ will identify the majority of women to be at low genetic risk. To date, no one has considered whether HBOC screening could be a "teachable moment" for encouraging the adoption of risk-stratified screening guidelines, particularly for women at low hereditary risk. Understanding how the majority of women who participate in HBOC screening perceive the implications of their results as they relate to breast cancer screening could have significant public health impact.

Despite the established utility of mammography screening for early detection of breast cancer, mammograms can yield false positive results that produce unwarranted fear and psychological stress, and expose women to unnecessary treatment, pain, side effects, and health care costs^[@CR7]^. Half of all women getting annual mammograms beginning at age 40, over a 10-year period will be called back for what is determined to be a false positive finding^[@CR8]^. Additionally, societal health care costs attributed to annual mammography were estimated at 7.8 billion dollars in 2010^[@CR9]^. Screening frequency is one of the major drivers of these costs; adoption of USTPSTF guidelines would reduce these costs by half to 3.5 billion^[@CR9]^. Thus, increasing breast cancer screening intervals for those not deemed to be at high inherited risk could reduce adverse consequences and lower health care costs^[@CR10]--[@CR14]^.

Convincing women at low risk for HBOC that they could start screening at a later age or decrease the frequency of their mammograms will likely be very challenging, despite the sizeable risk-benefit tradeoff related to the frequency of screening. As evidence, mammography rates did not decrease following the release of the 2009 USPSTF guideline supporting less frequent mammograms starting at age 50^[@CR15]--[@CR17]^. Women did not view these guideline changes favorably, and reacted to reductions in mammography frequency with feelings of distrust as they felt the guideline change was driven by cost saving efforts on the part of insurance companies as opposed to improving their health^[@CR18],[@CR19]^. This may be particularly true for women from minority groups who have experienced health care discrimination, commonly report lower trust in health care systems^[@CR20]^ and are more skeptical of genomics^[@CR21]^. Although many women had stories of anxiety and discomfort related to mammograms, the majority of women stated that they intended to continue with annual screenings, with some wanting screenings more than once a year from an earlier age^[@CR18]^. While screening practices that are contrary to guideline recommendations are common, the determinants of patient receptivity to shifting mammography screening frequency have yet to be explored.

Conceptual models of information processing can provide a framework for considering factors that might influence willingness to reduce mammography frequency. These models suggest both cognitive and emotional factors that together influence how individuals respond to risk information^[@CR22],[@CR23]^. Important cognitive factors include risk-related knowledge, perceived salience and reliability of information. This level of processing is influenced in turn, by emotional factors such as worry and fear that can motivate self-protective reasoning and influence how risk information is interpreted^[@CR22]^. Thus, consideration of these factors will be critical to any efforts to engage women to thoughtfully consider decreasing mammography screening.

To this end, we conducted an exploratory study aimed to assess women's willingness to alter mammogram frequency based on their low likelihood to be at risk for HBOC, and to examine if individual cognitive and emotional factors suggested by information processing frameworks are associated with women's inclination to decrease mammogram frequency.

Materials and Methods {#Sec2}
=====================

Pilot study design and population {#Sec3}
---------------------------------

This pilot study was a substudy of a larger project aimed at increasing identification and referral of women at highest risk for HBOC to genetic services. Women were approached in the waiting rooms of three Emory clinic breast imaging centers to complete an HBOC screening tool between April 2016 and June 2017. The Breast Cancer Genetics Referral Screening Tool version 3.0 (B-RST^TM^ 3.0, www.brcagenescreen.org) was used^[@CR24]^. B-RST^TM^ has been endorsed by the USPSTF as one of several validated screening tools that are clinically useful for estimating the probability of *BRCA1/2* mutations and identifying women who should be referred for cancer genetic counseling^[@CR1]^. This tool uses a validated algorithm which includes breast cancer (\<40 years old, 40--50 years old, \>50, years old), bilateral breast cancer, ovarian cancer, male breast cancer and Ashkenazi Jewish ancestry in 1^st^ and 2^nd^ degree relatives^[@CR24]--[@CR26]^. It should be noted that the B-RST^TM^ does not incorporate other breast cancer risk factors (e.g., smoking, alcohol consumption, age at menarche, age at first live birth of child) for breast cancer risk assessment. The B-RST^TM^ provides two categories of risk results for *BRCA1/2* mutation based on family history: "positive" and "negative". Individuals who screen "positive" are at heightened risk for carrying a *BRCA1/2* mutation and directed to receive genetic counseling. The "negative" category is further sub-divided into "negative-average risk" and "negative-moderate risk", reflective of the expected familial risk for breast cancer aside from carrying a mutation in *BRCA1/2*. Women who screened as negative-average risk were told that they were unlikely to carry a *BRCA1/2* mutation and were at average population risk for breast cancer based on family history. Those who screened as negative-moderate risk were told they were at low risk (less than 5%) of carrying a *BRCA1/2* mutation, and at greater than average population risk for breast cancer.

Our substudy focused on women who received a negative-average B-RST^TM^ screening result. Women with negative-average results were chosen as they represent the group who could benefit from increasing age at initiation and reducing mammography frequency. Women were recruited using a recruitment flyer included in the resource handout materials that were given to patients immediately after completing the B-RST^TM^. The flyer explained briefly that women would be asked to complete a one-time online 20-minute survey regarding understanding of the screen result. Those who were interested were asked to provide an email address to the research team. In addition, all eligible women who consented to be recontacted received an email approximately 2--6 weeks after receiving their B-RST^TM^ results, with an invitation to consent and participate in the online survey. Participants received a \$25 Amazon electronic gift card via email upon completion of the survey.

A total of 3,883 women were approached to complete the B-RST^TM^ and 2,429 (62.6%) completed the screening. Among 1,768 women who screened negative (1461 negative-average risk and 307 negative-moderate risk), about 500 were contacted for the online survey. 124 women with a negative-average risk result completed the online survey. All research activities were reviewed and approved by Institutional Review Boards at the Emory University.

Measures {#Sec4}
--------

Willingness to decrease mammogram frequency was assessed with the item "How willing would you be to have mammography screening less often if you were found to be at lower genetic risk of breast cancer based on the B-RST^TM^ result?" Possible responses were: very unwilling, unwilling, not sure, willing, very willing. Participants' responses were categorized into willing, unwilling, and unsure.

### Cognitive factors {#Sec5}

Perceived need for biannual mammogram: Participants were provided with the stem question, "Based on what you know about mammography screening recommendations for your age" and asked to endorse the recommended mammography frequency: biannual, annual, depends on doctor recommendation, and I don't know. Women's perceived need for biannual mammogram was calculated as the agreement between their understanding of mammogram frequency and the USPSTF guideline (biannual for low risk women). Provider perceived need for biannual mammogram was assessed from the patient perspective using one 5-point Likert item, "My health care provider thinks that I should have a mammogram every two years."

Risk perception: Relative risk perception was assessed by the item "compared to the average woman your age, would you say that you are less likely/as likely/more likely to develop breast cancer." Risk perception alignment was the 100% agreement of women's perceived risk with their B-RST^TM^ risk estimation: "negative-average risk" (as likely as the average woman).

Knowledge: Breast cancer genetic knowledge was assessed using a validated scale developed by Lerman^[@CR27]^ and Erblich^[@CR28]^. It includes seven items with response options of "true", "false" and "don't know" to questions such as: "Ovarian cancer and breast cancer in the same family can be a sign of an inherited *BRCA1* or *BRCA2* mutation." Recall of B-RST^TM^ result was scored as correct or incorrect and calculated as the concordance of participants' self-reported screen result and their actual result. Understanding of results (correct/incorrect) was assessed by two items regarding the likelihood of carrying a *BRCA1/2* mutation and the likelihood of breast cancer based on family history. B-RST^TM^ result acceptance was assessed by a 9-item 5-point Likert scale^[@CR29]^, where participants were asked to respond to statements including "The information I received from the B-RST™ result about my risk for hereditary breast and ovarian cancer seems accurate" and "The information I received from the B-RST™ result was missing some important information about me or my family" (reverse-scored). Sum scores range from 0--45, with a higher score indicating a higher level of acceptance (Cronbach's Alpha = 0.79).

Trust: Trust in health care provider was measured on a 5-point Likert scale using five items from the multidimensional trust in health care systems scale^[@CR30]^. Participants were asked to respond to statements including "My health care provider will do whatever it takes to give me the medical care that I need" (Cronbach's Alpha = 0.96). Trust in breast cancer screening guidelines was measured on a 5-point Likert 5-item scale. Participants were asked to "think about national recommendations for breast cancer screening" and indicate whether they agreed or disagreed with statements such as: "The recommendations for breast cancer screening I have heard are trustworthy" (Cronbach's Alpha = 0.92).

### Emotional factors {#Sec6}

Cancer worry: Women were asked how often they worried about getting breast cancer with response options from "rarely or never" to "all the time" on a 4-point Likert scale^[@CR31]--[@CR33]^.

Negative affect: A shortened 5-item Positive and Negative Affect Schedule (PANAS) scale^[@CR34]^ was used to measure emotions that might be generated by breast cancer risk information. Women were provided with the stem question, "When I think about breast cancer" and then asked to endorse the extent to which they felt: anxious, calm (reverse coded), upset, confident (reverse coded), and uneasy (Cronbach's Alpha = 0.89). Total score ranges from 0 to 5; a higher score indicates more negative affect of breast cancer.

### Mammogram history {#Sec7}

Reason for current mammogram: Participants were asked to indicate the reason for their mammogram at the time of the B-RST^TM^ screen. Possible responses were: personal choice for routine screening and doctor recommendation for routine screening.

Past mammogram frequency: Women were asked to report how frequently they had a mammogram in the past two years with answers grouped to "biannually or less" (consistent with USPSTF guideline) or "annually or more."

### Demographics {#Sec8}

Participants age, race, level of education, and annual household income were measured using items developed from the U.S. Census guidelines^[@CR35]^. We used a dichotomized age variable (\<50 years, \>=50 years) to reflect the USPSTF mammogram screening guideline^[@CR2]^. Health literacy was assessed by a single item, "How confident are you filling out medical forms by yourself?" This has been shown to be accurate in detecting inadequate health literacy skills^[@CR36],[@CR37]^.

Statistical analysis {#Sec9}
--------------------

Survey responses were collated into Microsoft Excel from REDCap, and all data analyses were performed using STATA Version 15.0 (STATA Corp, College Station, Texas, USA). Descriptive statistics analyzed the demographic and outcome variables to describe the study participants. There was no significant difference between the "unwilling" and "unsure" group in the following patient factors: patient socio-demographic characteristics (age, race, education, income, health literacy), emotional factors (cancer worry and negative affect), cognitive factors (risk perception, genetic risk knowledge, B-RST^TM^ result recall and understanding, trust in health care), and mammogram history (reason for current mammogram, past mammogram frequency, and patient and provider perceived need for biannual mammogram). To increase power, we combined the "unwilling" and "unsure" groups to be one group, "not willing," in subsequent logistic regression analyses with "not willing" as the reference category. The dichotomized outcome, willing vs. not willing to decrease screening frequency, was regressed on each of the patient factors separately. In all analyses, 2-tailed tests and p-values \< 0.05 were used to draw conclusions regarding statistical significance.

Ethical approval {#Sec10}
----------------

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent {#Sec11}
----------------

Informed consent was obtained from all individual participants included in the study.

Results {#Sec12}
=======

Participants demographics and mammogram history {#Sec13}
-----------------------------------------------

The majority of negative-average risk women (i.e., unlikely to have a BRCA mutation and at average population risk for breast cancer based on family history) were either white (50%) or African American (38%) and were 50 years or older (74%) (Table [1](#Tab1){ref-type="table"}). About one-third of women reported being extremely confident to fill out medical forms, an indicator of high health literacy. The majority of women reported at least college education (75%) and half (50%) reported annual household incomes greater than \$75 K.Table 1Descriptive results of patient characteristics by women's willingness to decrease mammogram frequency.Patient factorsAll (N = 124)Willingness to decrease mammogram frequencyYes (n = 40)No (n = 52)Unsure (n = 32)**Socioeconomic characteristics**Age, mean (SD, range)57.7 (10.5, 34--87)58.7 (11.6)55.9 (10.4)59.2 (9.1)  \<50 years32 (26%)9 (23%)17 (33%)6 (19%)  \>=50 years92 (74%)31 (77%)35 (67%)26 (81%)Race  White62 (50%)20 (50%)24 (46%)18 (56%)  African American48 (38%)13 (33%)25 (48%)10 (31%)  Other (e.g., Asian, American Indian, Not specified)14 (12%)7 (17%)3 (6%)4 (13%)Education  Some college or less26 (25%)6 (19%)14 (33%)6 (21%)  College graduate34 (33%)7 (23%)18 (42%)9 (31%)  Graduate or professional degree43 (42%)18 (58%)11 (25%)14 (48%)Household Income  Less than \$50,00027 (29%)7 (26%)12 (32%)8 (29%)  \$50,001-\$75,00020 (21%)5 (19%)9 (24%)6 (21%)  \$75,001 and over46 (50%)15 (55%)17 (44%)14 (50%)Health Literacy  Less than extremely confident15 (12%)7 (17%)4 (8%)4 (13%)  Extremely confident44 (35%)13 (33%)20 (38%)11 (34%)  Do not wish to answer65 (53%)20 (50%)28 (54%)17 (53%)**Emotional factors**Breast cancer worry  No worry58 (47%)26 (65%)18 (35%)14 (44%)  Any worry66 (54%)14 (35%)34 (65%)18 (56%)Breast cancer negative affect, mean (SD, range)14.5 (4.8, 5--24)2.9 (1.1)3.1 (1.3)3.1 (1.2)**Cognitive factors**Relative risk perception  More likely7 (6%)1 (2%)6 (8%)0  Less likely53 (45%)17 (45%)22 (46%)14 (47%)  As likely (Consistent with B-RST^TM^ estimate)58 (49%)20 (53%)22 (46%)16 (53%)Risk perception alignment with B-RST^TM^ estimate  Inconsistent (more or less likely)66 (53%)18 (47%)28 (54%)14 (47%)  Consistent (as likely)58 (47%)20 (53%)22 (46%)16 (53%)  Genetic risk knowledge, mean (SD, range)4.0 (1.4, 0--7)3.6 (1.3)4.2 (1.3)4.3 (1.7)B-RST^TM^ result recall  Wrong63 (54%)20 (56%)26 (52%)17 (57%)  Correct53 (46%)16 (44%)24 (48%)13 (43%)B-RST^TM^ understanding of BRCA mutation risk  Wrong53 (45%)19 (51%)20 (40%)14 (47%)  Correct64 (55%)18 (49%)30 (60%)16 (53%)B-RST^TM^ understanding of general population risk  Wrong72 (62%)28 (76%)27 (55%)17 (57%)  Correct44 (38%)9 (24%)22 (45%)13 (43%)  B-RST^TM^ acceptance32.6 (4.9, 22--45)32.6 (4.8)32.7 (5.6)32.2 (3.7)  Trust in health care providers, mean (SD, range)20.3 (4.2, 5--25)20.0 (3.9)20.5 (4.5)20.5 (4.3)  Trust in screening guidelines, mean (SD, range)18.9 (3.5, 5--25)18.9 (2.2)18.6 (4.5)19.5 (3.1)**Mammogram history**Reason for current mammogram  Personal choice for routine screening42 (36%)10 (29%)19 (38%)13 (41%)  Doctor recommendation for routine screening75 (64%)25 (71%)31 (62%)19 (59%)Past mammogram frequency  Biannually or less (consistent with USPSTF guideline)18 (14%)13 (33%)2 (4%)3 (9%)  Annually or more105 (86%)27 (67%)49 (96%)29 (91%)Understanding of mammogram screening frequency based on age  Biannual (consistent with USPSTF guideline)13 (10%)3 (7%)5 (10%)5 (16%)  Annual82 (67%)25 (63%)35 (67%)22 (71%)  Depend on doctor recommendation20 (16%)8 (20%)8 (15%)4 (13%)  I don't know8 (7%)4 (10%)4 (8%)0Women perceived need for biannual mammogram  Biannual (consistent with USPSTF guideline)13 (11%)3 (7%)5 (9%)5 (16%)  Other (annual, depend on doctor recommendation, I don't know)110 (89%)39 (93%)48 (91%)26 (84%)Provider perceived need for biannual mammogram  Do not agree106 (85%)32 (80%)46 (88%)28 (87%)  Agree18 (15%)8 (20%)6 (12%)4 (13%)

The reason for women's current mammogram was for routine screening, either due to personal choice (n = 42) or doctor recommendation (n = 75). Few women reported having had a mammogram biannually or less frequently in the past two years (14%, n = 18), believed that they should have biannual mammogram based on age (11%, n = 13), or agreed their doctor would support biannual mammogram (15%, n = 18).

Willingness to change the frequency of mammograms {#Sec14}
-------------------------------------------------

One third (n = 40) of women reported being willing to decrease screening (as consistent with the USPSTF guideline), 42% (n = 52) reporting being "unwilling" and 26% (n = 32) were "unsure" about decreasing mammogram frequency.

Emotional factors related to breast cancer {#Sec15}
------------------------------------------

Over half (54%) of women reported feeling worried at least sometimes about getting breast cancer. Breast cancer-related negative affect was moderate (mean = 14.5, range: 5--24). In particular, more than one-third women agreed or strongly agreed that they felt uneasy (48%), or anxious (44%) when they thought about breast cancer.

Cognitive factors related to breast cancer {#Sec16}
------------------------------------------

Half of the women perceived themselves to be as likely to develop breast cancer as other women their age (as depicted on their actual B-RST^TM^ result) while 44% indicated they were at lower risk and 6% indicated they were at higher risk.

Women demonstrated a moderate level of knowledge related to factors that influence breast cancer risk (mean = 4.0, SD = 1.5, range: 0--7). The majority of women responded correctly that: *"ovarian cancer and breast cancer in the same family can be a sign of an inherited BRCA1/2 mutation"* (78%), *"there are many different genes that when altered can increase cancer risk"* (80%), and *"a woman who does not have a BRCA1/2 gene mutation can still get breast or ovarian cancer"* (79%). However, most women (87%) incorrectly agreed "*that about half of all breast cancers are caused by mutations in BRCA1 and BRCA2"*.

Less than half of women (46%, 53/116) accurately reported their B-RST^TM^ result as "negative-average risk". Over half of the women (55%, 64/117) correctly interpreted that their negative-screen result indicated it was *unlikely* that they carried a *BRCA1/2* mutation, but fewer women (38%, 44/116) correctly understood that they remained at average risk for breast cancer. B-RST^TM^ result acceptance (based on a 9-item scale -- e.g. *"The information I received from the B-RST*^*TM*^ *result about my risk for HBOC seems accurate*") was high (mean = 32.6, SD = 4.9, range: 22--45).

Women reported relatively high trust in health care providers (mean = 20.3, SD = 4.2, range: 5--25), but their trust in national professional mammogram screening guidelines was relatively lower (mean = 18.9, SD = 3.5, range: 5--25).

Association between information processing factors and women's willingness to decrease mammogram frequency {#Sec17}
----------------------------------------------------------------------------------------------------------

As shown in Table [2](#Tab2){ref-type="table"}, bivariate logistic regressions showed that women who had any worry about breast cancer were less likely to be willing to decrease mammogram frequency, compared to women who reported no worry (OR = 0.33, 95% CI: 0.15--0.73; p = 0.006). Knowledge was negatively associated with willingness to decrease screening frequency; greater knowledge of breast cancer genetic risk (OR = 0.74, 95% CI: 0.57--0.97; p = 0.03) and correct interpretation of the implications of HBOC screen results for breast cancer risk (OR = 0.40, 95% CI: 0.17--0.97; p = 0.04) were associated with not being willing to decrease mammogram frequency. Women who had annual or more frequent mammograms within the past two years (OR = 0.13, 95% CI: 0.04--0.41; p \< 0.001) were less likely to be willing to decrease mammogram frequency. Other information processing factors (e.g., trust, acceptance of risk information relevance, risk perception) were not significantly associated with willingness to reduce screening frequency.Table 2Association between information processing factors and women's willingness to decrease mammogram frequency: Results from bivariate logistic regressions with "Not willing" as the reference category.Patient factorsWilling (n = 40) vs Not willing (n = 84)OR (95%CI)p-value**Socioeconomic characteristics**Age  \<50 years (REF)  \>=50 years1.30 (0.54--3.14)0.56**Race**African American (REF)  White1.28 (0.56--2.94)0.56  Other (e.g., Asian, American Indian, Not specified)2.69 (0.79--9.17)0.11Education  Some college or less (REF)  College graduate0.86 (0.25--2.97)0.82  Graduate or professional degree2.40 (0.80--7.18)0.12**Household Income**Less than \$50,000 (REF)  \$50,001-\$75,0000.95 (0.25--3.60)0.94  \$75,001 and over1.38 (0.48--3.99)0.55**Health Literacy**Less than extremely confident (REF)  Extremely confident0.48 (0.14--1.60)0.23  Do not wish to answer0.51 (0.16--1.59)0.25**Emotional factors**Breast cancer worry  No worry (REF)  Any worry0.33 (0.15--0.73)0.006Breast cancer negative affect0.99 (0.91--1.07)0.73**Cognitive factors**Relative risk perception  Inconsistent with B-RST^TM^ estimate (REF)  Consistent with B-RST^TM^ estimate1.21 (0.57--2.57)0.62  Genetic risk knowledge0.74 (0.57--0.97)0.03**B-RST** ^**TM**^ **result recall**Wrong (REF)  Correct0.93 (0.42--2.05)0.86B-RST^TM^ understanding of BRCA mutation risk  Wrong (REF)  Correct0.70 (0.32--1.53)0.37B-RST^TM^ understanding of general population risk  Wrong (REF)  Correct0.40 (0.17--0.97)0.04B-RST^TM^ acceptance1.00 (0.92--1.09)0.96Trust in health care providers0.98 (0.90--1.07)0.63Trust in screening guidelines1.00 (0.90--1.11)0.98**Mammogram history**Reason for current mammogram  Personal choice for routine screening (REF)  Doctor recommendation for routine screening1.60 (0.68--3.77)0.28Past mammogram frequency  Biannually or less (consistent with USPSTF guideline) (REF)  Annually or more0.13 (0.04--0.41)\<0.001Women perceived need for biannual mammogram  Other (annual, depend on doctor recommendation, I don't know) (REF)  Biannual (consistent with USPSTF guideline)0.59 (0.15--2.28)0.45Provider perceived need for biannual mammogram  Do not agree (REF)  Agree1.85 (0.67--5.12)0.24

Although our power was limited, we conducted selected multivariate logistic regression analyses. Significant patient factors identified from the bivariate logistic regressions were included in the final multivariate logistic regression model: cancer worry, genetic risk knowledge, and past mammogram frequency. Results indicated that feeling worried about breast cancer (Adjust OR = 0.33, 95% CI = 0.14--0.77; p = 0.01), greater genetic risk knowledge scores (Adjust OR = 0.74, 95% CI = 0.56--1.00; p = 0.047), and more frequent past mammogram screening (Adjust OR = 0.13, 95% CI: 0.04--0.42; p = 0.001) were associated with being less willing to decrease screening frequency (pseudo r-square = 0.17).

Discussion {#Sec18}
==========

To our knowledge, this is the first study to explore how women screened at low risk of being *BRCA1/2* mutation carriers might respond to recommendations for decreased frequency of mammogram screening. These women make up the majority of women who participate in HBOC screening. Women who receive a "negative-average" HBOC screen result are unlikely to have a *BRCA* mutation and are at average population risk for breast cancer based on family history^[@CR24]^. National guidelines support initiating mammography at age 50 with biannual screening thereafter^[@CR2]^. We found that a large proportion of women (86%) in the study had adopted routine annual mammogram screening regimen, which is in excess of guideline recommendation. After learning that they were at lower genetic risk of breast cancer, over half (67%) reported that they were either unwilling or unsure about reducing mammography screening. These preliminary results suggest that proactive efforts would be needed to sway the large proportion of low risk women to consider reducing mammography screening frequency.

We further explained how individual emotional and cognitive factors influence how willing women may be to adjust their screening based on their genetic risk, guided by information processing models^[@CR22],[@CR23]^. This approach was particularly novel, as past studies of "deimplementation" of medical overuse have focused on provider and contextual factors^[@CR38],[@CR39]^ and not on patients' processes of "unlearning" ineffective health behaviors. Results from this study support some of the proposed relationships, most notably those between breast cancer worry, genetic risk knowledge, past mammogram frequency, and women's willingness to decrease mammogram screening.

Cancer worry was significantly associated with women being less willing to adopt less frequent mammography screening. The effect of breast cancer worry on screening behavior has been inconsistent; worry may enhance screening^[@CR40]^ or lead to screening avoidance^[@CR41]^. Unfortunately, we did not assess worry related to the likelihood of false positive results. Others have shown with a sample of women ages of 40 and 59 that awareness of over-diagnoses (27%) or overtreatment (40%) due to mammography was low^[@CR42]^. Prior work has also shown that women experience anxiety about guideline changes and prefer not to change the frequency of their use of mammography^[@CR18]^. Due to the widely reinforced mammogram recommendation as the way to prevent breast cancer, negative emotions associated with breast cancer likely would need to be addressed in helping women consider less frequent mammograms. Future larger studies should include a broader array of emotion-related measures based on information processing frameworks.

Greater genetic risk knowledge related to breast cancer was associated with *not* being willing to decrease mammogram frequency. We evaluated whether heightened knowledge might be due to cancer worry prompting more information seeking or lessened trust. However, we did not find significant associations between knowledge and worry or trust in this population. Unfortunately, the small sample size precluded us from testing moderating and mediating associations. Given these factors, intervention efforts that solely focus on improving the public's cancer genetic knowledge may not serve the goal of promoting adoption of evidence-based screening guidelines. Understanding how different types of knowledge impact women's willingness to de-implement, when appropriate, annual mammogram screening based on their genetic risk, and how relevant knowledge interacts with women's emotional factors, will be critical to facilitate effective decision making for patients.

We also found that women who had annual or more frequent screening in the past were less likely to forgo future mammograms based on learning more about their breast cancer risk. This finding is consistent with previous research^[@CR38],[@CR43],[@CR44]^. The interplay between emotion- and cognition-based processing of the HBOC screen result may be particularly important to the mammogram decision against the backdrop of discrepancies in public messages about mammography^[@CR45]^, the complexity of risk factors of breast cancer, and the uncertainty of potential harms (e.g., likelihood of getting a false-positive mammogram screen result)^[@CR46]^. Women faced with this discrepant information will likely default to previous screening behaviors rather than to act on uncertain information. It is evident that most women in the study believed that they should have annual mammogram based on age (90%) and did not believe their doctor would support biennial mammogram (85%). In the context of the widely reinforced one-size-fits-all annual mammogram recommendation being deeply ingrained into patients' and providers' perceptions of appropriate medical care, and with public health organizations and advocacy groups pushing screening through advertisements and media campaigns^[@CR47]^, effectively implementing risk stratified mammogram screening recommendations may be challenging.

We acknowledge that our study findings are limited due to small sample and require replication. While it was difficult to assess the actual participation, survey completion of 124 from 500 contacted, while not unusual, may have resulted in a highly selective sample. Accordingly, the sample was relatively homogeneous with respect to education, income, and other demographics. Women who were recruited at mammography clinics in one medical system and responded to the survey may not be generalizable to women outside of this context. The small sample size also limited power to explore associations among patient factors and women's willingness to decrease mammogram frequency. In addition, it should be noted that the B-RST^TM^ was developed and validated as a tool to identify individuals at increased risk for *BRCA1/2* mutations and it does not incorporate other breast cancer risk factors (e.g., smoking, alcohol consumption, age at menarche, age at first live birth of child). As such, its predictions for breast cancer risk in the average and moderate range are limited to family history-based information. It should be noted however, that the screen result information sheet did describe non-familial risk factors for breast cancer. Women's perceptions of the need for annual mammograms may have been influenced by these risk factors.

Despite these limitations, our findings show that, while some women at low genetic risk for breast cancer were willing to decrease mammogram frequency consistent with the USPSTF guideline, more were unwilling or unsure about reducing the frequency of mammography. Our sample likely represents the most adherent mammography screening population given that the majority of women adopted routine annual screening schedule. The resistance of guideline change among these well-educated adherent screeners may be suggestive of broader resistance to de-implementing annual mammograms among an average risk population of screeners. The use of screening mammography in excess of guidelines by low risk women could divert health care resources from those who benefit most from screening. Moreover, resulting false positive screening results in unnecessary diagnostic work-up, and biopsies could also divert limited health services^[@CR10]--[@CR14]^. To increase the likelihood of adopting genomics-informed medical recommendations, further study of the interplay between emotion- and cognition-based processing of the HBOC screen result will be important, particularly for strategizing communication interventions aimed at realizing the potential of precision public health.
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